In January 2006 an independent study with no-ties to big pharmaceutical funding proved that Trasylol (aprontin) had doubled a patient's risk to kidney dialysis and increased the risk of heart attack, heart failure, and stroke.
Bayer AG's aprotin has been on the worldwide market since 1993 and given to an estimated one million patients. As the demand for heart bypass surgery grows so does the need for kidney dialysis. What has become almost a routine cardiac surgery is now much more dangerous when patients receive aprontin to curb blood loss.
These results were based on an independent, observational study conducted by the Ischemia Research and Education Foundation (IREF), in association with the McSPI Research Group, both nonprofit biomedical research organizations, dedicated to saving and extending lives.
According to the study replacing Trasylol with one of two safe generic drugs would annually prevent as many as 11,000 kidney dialysis complications; save at least $1 billion in healthcare (dialysis) costs; and reduce drug costs by at least $250 million.
Figures show that each year approximately one million patients worldwide undergo surgical treatment following a heart attack, with the majority of these patients receiving one of three antifibrinolytic agents to limit blood loss during surgery, Trasylol produced by Bayer Healthcare, or one of the generic drugs aminocaproic acid and tranexamic acid.
The two generic drugs have proven safe in limiting blood loss and do not have the harmful effects of Trasylol. Patients scheduled for cardiac surgery are advised to consult their physician and avoid this risk. Unfortunately, most patients are not that savvy and simply trust the decision of their doctors and hospitals.
If you or a loved has suffered from kidney damage, heart attack,
stroke, or death while taking Trasylol, you may be entitled to
compensation for your medical expenses, pain and suffering, and
more. Contact our service today to get in touch with experienced
Trasylol attorneys to discuss your case.
Select a State.
Make Contact. After choosing a state, submit your case and we will send it to all the participating attorneys in your area.
Make the Decision. Based on the responses you receive, choose the attorney you are most comfortable with. Response times may vary.
